Medicare plans to restrict access to controversial, pricey Alzheimer’s drug Aduhelm to patients in clinical trials
(By Rachel Cohrs for STAT) WASHINGTON — Medicare plans to cover the controversial, pricey Alzheimer’s drug Aduhelm, but only for
Read More